IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHARON N CHASTAIN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1033299102
CMS profile
274074
Location
MARYVILLE, TN

General Payments · PY2018–2024

$9,605.13

  • Reported across 431 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,345.78

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry TN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,345.78 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $269.22 6
Otsuka America Pharmaceutical, Inc. $221.86 4
Janssen Pharmaceuticals, Inc $213.53 8
Alkermes, Inc. $203.08 8
Teva Pharmaceuticals USA, Inc. $139.36 11
Corium, Inc. $103.58 4
Supernus Pharmaceuticals, Inc. $63.15 3
ITI, Inc. $57.26 3
ABBVIE INC. $23.59 1
Axsome Therapeutics, Inc. $20.06 1
Lundbeck LLC $17.97 1
IRONSHORE PHARMACEUTICALS INC. $13.12 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,154.89 30
PY2019 $1,541.13 65
PY2020 $703.64 26
PY2021 $1,522.35 85
PY2022 $1,687.34 87
PY2023 $1,650.00 87
PY2024 $1,345.78 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.59 04/23/2024 Food and Beverage Undisputed 01/23/2026 1103447342 CMS
Alkermes, Inc. $15.99 04/30/2024 Food and Beverage Undisputed 01/23/2026 1120478372 CMS
Alkermes, Inc. $16.15 05/17/2024 Food and Beverage Undisputed 01/23/2026 1120478374 CMS
Alkermes, Inc. $19.62 06/06/2024 Food and Beverage Undisputed 01/23/2026 1120478376 CMS
Alkermes, Inc. $81.51 06/20/2024 Food and Beverage Undisputed 01/23/2026 1120478378 CMS
Alkermes, Inc. $14.25 09/17/2024 Food and Beverage Undisputed 01/23/2026 1120478380 CMS
Alkermes, Inc. $10.74 10/24/2024 Food and Beverage Undisputed 01/23/2026 1120478382 CMS
Alkermes, Inc. $27.68 11/19/2024 Food and Beverage Undisputed 01/23/2026 1120478384 CMS
Alkermes, Inc. $17.14 12/12/2024 Food and Beverage Undisputed 01/23/2026 1120478386 CMS
Axsome Therapeutics, Inc. $20.06 08/06/2024 Food and Beverage Undisputed 01/23/2026 1148320970 CMS
Corium, LLC $22.27 02/01/2024 Food and Beverage Undisputed 01/23/2026 1100090602 CMS
Corium, LLC $28.16 04/11/2024 Food and Beverage Undisputed 01/23/2026 1100077587 CMS
Corium, LLC $27.03 05/21/2024 Food and Beverage Undisputed 01/23/2026 1100079489 CMS
Corium, LLC $26.12 06/27/2024 Food and Beverage Undisputed 01/23/2026 1100081271 CMS
IRONSHORE PHARMACEUTICALS INC. $13.12 05/30/2024 Food and Beverage Undisputed 01/23/2026 1146243863 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.93 04/26/2024 Food and Beverage Undisputed 01/23/2026 1143205241 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.30 10/10/2024 Food and Beverage Undisputed 01/23/2026 1143205245 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.03 11/21/2024 Food and Beverage Undisputed 01/23/2026 1143205248 CMS
Janssen Pharmaceuticals, Inc $16.68 01/11/2024 Food and Beverage Undisputed 01/23/2026 1078185911 CMS
Janssen Pharmaceuticals, Inc $3.99 01/23/2024 Food and Beverage Undisputed 01/23/2026 1078185963 CMS
Janssen Pharmaceuticals, Inc $20.76 02/29/2024 Food and Beverage Undisputed 01/23/2026 1078185933 CMS
Janssen Pharmaceuticals, Inc $16.40 04/04/2024 Food and Beverage Undisputed 01/23/2026 1078185869 CMS
Janssen Pharmaceuticals, Inc $3.19 04/04/2024 Food and Beverage Undisputed 01/23/2026 1078185919 CMS
Janssen Pharmaceuticals, Inc $112.89 06/13/2024 Food and Beverage Undisputed 01/23/2026 1078185951 CMS
Janssen Pharmaceuticals, Inc $20.50 07/27/2024 Food and Beverage Undisputed 01/23/2026 1078185901 CMS
Janssen Pharmaceuticals, Inc $19.12 12/05/2024 Food and Beverage Undisputed 01/23/2026 1078185913 CMS
Lundbeck LLC $17.97 03/21/2024 Food and Beverage Undisputed 01/23/2026 1145904077 CMS
Neurocrine Biosciences, Inc. $23.71 02/13/2024 Food and Beverage Undisputed 01/23/2026 1150844064 CMS
Neurocrine Biosciences, Inc. $96.58 02/20/2024 Food and Beverage Undisputed 01/23/2026 1150812327 CMS
Neurocrine Biosciences, Inc. $91.20 05/07/2024 Food and Beverage Undisputed 01/23/2026 1150812624 CMS
Neurocrine Biosciences, Inc. $10.97 05/07/2024 Food and Beverage Undisputed 01/23/2026 1150881767 CMS
Neurocrine Biosciences, Inc. $23.89 10/17/2024 Food and Beverage Undisputed 01/23/2026 1150843484 CMS
Neurocrine Biosciences, Inc. $22.87 11/26/2024 Food and Beverage Undisputed 01/23/2026 1150847031 CMS
Otsuka America Pharmaceutical, Inc. $121.83 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118873674 CMS
Otsuka America Pharmaceutical, Inc. $3.33 05/23/2024 Food and Beverage Undisputed 01/23/2026 1118873676 CMS
Otsuka America Pharmaceutical, Inc. $4.16 06/27/2024 Food and Beverage Undisputed 01/23/2026 1118873678 CMS
Otsuka America Pharmaceutical, Inc. $92.54 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118873680 CMS
Supernus Pharmaceuticals, Inc. $30.12 01/31/2024 Food and Beverage Undisputed 01/23/2026 1147850671 CMS
Supernus Pharmaceuticals, Inc. $18.63 02/07/2024 Food and Beverage Undisputed 01/23/2026 1147850669 CMS
Supernus Pharmaceuticals, Inc. $14.40 11/04/2024 Food and Beverage Undisputed 01/23/2026 1147784792 CMS
Teva Pharmaceuticals USA, Inc. $5.63 01/22/2024 Food and Beverage Undisputed 01/23/2026 1151611572 CMS
Teva Pharmaceuticals USA, Inc. $17.68 03/12/2024 Food and Beverage Undisputed 01/23/2026 1151611594 CMS
Teva Pharmaceuticals USA, Inc. $8.68 03/20/2024 Food and Beverage Undisputed 01/23/2026 1151611606 CMS
Teva Pharmaceuticals USA, Inc. $5.46 03/26/2024 Food and Beverage Undisputed 01/23/2026 1151611596 CMS
Teva Pharmaceuticals USA, Inc. $18.25 04/18/2024 Food and Beverage Undisputed 01/23/2026 1151611608 CMS
Teva Pharmaceuticals USA, Inc. $19.96 05/15/2024 Food and Beverage Undisputed 01/23/2026 1151611642 CMS
Teva Pharmaceuticals USA, Inc. $7.59 06/14/2024 Food and Beverage Undisputed 01/23/2026 1151611644 CMS
Teva Pharmaceuticals USA, Inc. $12.87 07/09/2024 Food and Beverage Undisputed 01/23/2026 1151611652 CMS
Teva Pharmaceuticals USA, Inc. $14.91 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151611676 CMS
Teva Pharmaceuticals USA, Inc. $13.41 10/24/2024 Food and Beverage Undisputed 01/23/2026 1151611682 CMS
Teva Pharmaceuticals USA, Inc. $14.92 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151611700 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.